Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Multiple Myeloma 67Lymphoma, Follicular 21Lymphoma, Large B-Cell, Diffuse 17Lymphoma, Mantle-Cell 10Lymphoma 10Recurrence 7Neoplasms, Plasma Cell 7Lymphoma, B-Cell, Marginal Zone 7Lymphoma, Non-Hodgkin 6Leukemia, Lymphocytic, Chronic, B-Cell 6Smoldering Multiple Myeloma 4Neoplasms 3Neuroblastoma 2Neoplasm, Residual 2Myelodysplastic Syndromes 2Leukemia, Plasma Cell 2Leukemia, Myelomonocytic, Chronic 2Hematologic Diseases 2Burkitt Lymphoma 2Urinary Bladder Neoplasms 1Urethral Neoplasms 1Ureteral Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Malignant Plasma Cell Neoplasms 1Lymphoma, T-Cell, Peripheral 1Lymphoma, B-Cell 1Leukemia, Hairy Cell 1Leukemia 1

Interventions

Specimen Handling 5Nivolumab 4Magnetic Resonance Spectroscopy 4cabozantinib 3Gemcitabine 3enfortumab vedotin 2avelumab 2Ipilimumab 2Carboplatin 2CTLA-4 Antigen 2Biopsy 2trastuzumab deruxtecan 1relatlimab 1pembrolizumab 1eribulin 1erdafitinib 1atezolizumab 1Lenalidomide 1Doxorubicin 1Contrast Media 1Cisplatin 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urethral Neoplasms × Lenalidomide × 90 days × Clear all
NCT01352962 2026-04-14

Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
18 enrolled
GastrointestinalGenitourinaryGynecologicThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Pancreatic Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡